The angiotensin-converting enzyme gene family: Genomics and pharmacology

Trends in Pharmacological Sciences

Volumn 23, Issue 4, 2002, Pages 177-183

  Turner, Anthony J ^a   Hooper, Nigel M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; BRADYKININ; CAPTOPRIL; CERANAPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRILAT; G PROTEIN COUPLED RECEPTOR; METALLOPROTEINASE; RAMIPRIL;

DNA LIBRARY; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME SPECIFICITY; ENZYME SYNTHESIS; GENOMICS; HUMAN; HYDROLYSIS; HYPERTENSION; KIDNEY INJURY; MOLECULAR CLONING; MULTIGENE FAMILY; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEQUENCE HOMOLOGY;

ANIMALS; EVOLUTION, MOLECULAR; GENOMICS; HUMANS; PEPTIDYL-DIPEPTIDASE A;

EID: 0036535405     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01994-5     Document Type: Review

References (66)

1. The renin-angiotensin system
2. Angiotensin receptors: Distribution, signalling and function
3. Potentiation of bradykinin actions by ACE inhibitors
4. A human homolog of angiotensin converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase
5. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
6. The preparation and function of the hypertensin-converting enzyme
7. Peptidyl-dipeptidase A/angiotensin I-converting enzyme
8. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice
9. Pig kidney angiotensin converting enzyme. Purification and characterization of amphipathic and hydrophilic forms of the enzyme establishes C-terminal anchorage to the plasma membrane
10. Characterization of a secretase activity which releases angiotensin-converting enzyme from the membrane
11. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin
12. 2- and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone
13. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning
14. Introduction: Other families in Clan MA
15. Molecular cloning of human testicular angiotensin-converting enzyme: The testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme
16. Structure of the angiotensin I converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene
17. Differences in properties and enzymatic specificities between the two active sites of angiotensin I-converting enzyme. Studies with bradykinin and other natural peptides
18. The haemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme
19. 1098 is critical for the chloride dependence of human angiotensin I-converting enzyme C-domain catalytic activity
20. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors
21. Two binding-sites on angiotensin-converting enzyme: Evidence from radioligand binding studies
22. Angiotensin-converting enzyme secretase is inhibited by zinc metalloprotease inhibitors and requires its substrate to be inserted in a lipid bilayer
23. Alzheimer's amyloid precursor protein α-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: Similarities to the angiotensin converting enzyme secretase
24. Membrane protein secretases
25. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
26. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α
27. Protein processing mechanisms: From angiotensin-converting enzyme to Alzheimer's disease
28. The secretases that cleave angiotensin converting enzyme and the amyloid precursor protein are distinct from tumour necrosis factor-α convertase
29. Unaltered cleavage and secretion of angiotensin-converting enzyme in tumor-necrosis factor-α-converting enzyme-deficient mice
30. Cleavage processing of angiotensin-converting enzyme by a membrane-associated metalloprotease
31. Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites
32. Design of angiotensin-converting enzyme inhibitors
33. Angiotensin-converting enzyme inhibitors
34. Identification of two active site residues in human angiotensin I-converting enzyme
35. Metallocarboxypeptidases and their protein inhibitors. Structure, function and biomedical properties
36. Carboxypeptidase Taq, a thermostable zinc enzyme, from Thermus aquaticus YT-1: Molecular cloning, sequencing, and expression of the encoding gene in Escherichia coli
37. Carboxypeptidase Taq
38. Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart
39. Important role for angiotensin III and IV in the brain renin-angiotensin system
40. Angiotensin III: A central regulator of vasopressin release and blood pressure
41. 4 receptor in a human neuroblastoma cell line (SK-N-MC)
42. A role for the angiotensin IV/AT4 system in mediating natriuresis in the rat
43. 4) receptor is the enzyme insulin-regulated aminopeptidase
44. The globin fragment LVV-hemorphin-7 is an endogenous ligand for the AT4 receptor in the brain
45. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system
46. Angiotensin-(1-7): A member of circulating angiotensin peptides
47. Pathways for angiotensin-(1-7) metabolism in pulmonary and renal tissue
48. Contribution of angiotensin-(1-7) to blood pressure regulation in salt-depleted hypertensive rats
49. Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor
50. Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm
51. Formation of angiotensin-II and other angiotensin peptides from [des-Leu-10]-angiotensin-I in rat lung and kidney
52. N-domain specific substrate and C-domain inhibitors of angiotensin converting enzyme
53. The angiotensin II AT2 receptor is an AT1 receptor antagonist
54. The B1 receptors for kinins
55. Purification and characterization of a peptidyl dipeptidase resembling angiotensin converting enzyme from the electric organ of Torpedo marmorata
56. Insect angiotensin-converting enzyme - A processing enzyme with broad substrate specificity and a role in reproduction
57. A novel peptide-processing activity of insect peptidyl-dipeptidase A (angiotensin I-converting enzyme): The hydrolysis of lysyl-arginine and arginyl-arginine from the C-terminus of an insect prohormone peptide
58. Hydrolysis by somatic angiotensin-I converting enzyme of basic dipeptides from a cholecystokinin/gastrin and a LH-RH peptide extended at the C-terminus with Gly-Arg/Lys-Arg, but not from diarginyl insulin
59. Cloning and expression of an evolutionary conserved single-domain angiotensin-converting enzyme from Drosophila melanogaster
60. The Acer gene of Drosophila codes for an angiotensin-converting enzyme homologue
61. The Drosophila melanogaster-related angiotensin-I-converting enzymes Acer and Ance - Distinct enzymic characteristics and alternative expression during pupal development
62. Functional conservation of the active sites of human and Drosophila angiotensin I-converting enzyme
63. Exploring the Caenorhabditis elegans and Drosophila melanogaster genomes to understand neuropeptide and peptidase function
64. Post-translational modifications of proteins: Acetylcholinesterase as a model system
65. Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys
66. Vasopeptidase inhibitors: An emerging class of cardiovascular drugs